- Based on the ARIEL3 findings, Clovis Oncology plans to submit a sNDA to the FDA for a second line or later maintenance treatment indication in ovarian cancer by the end of October 2017.
- In early 2018, the Company plans to file an MAA in Europe for the maintenance treatment indication upon receipt of a potential approval for the treatment indication.
- Co has entered into a restructuring agreement with more than 97 percent of its secured bank lenders, approximately 40 percent of its bondholders and a consortium of investors led by its largest shareholder, Hemen Holding Ltd.
- The agreement delivers $1.06 billion of new capital comprised of $860 million of secured notes and $200 million of equity. The Company's secured lending banks have agreed to defer maturities of all secured credit facilities, totaling $5.7 billion, by approximately five years with no amortization payments until 2020 and significant covenant relief. Additionally, assuming unsecured creditors support the plan, the Company's $2.3 billion of unsecured bonds and other unsecured claims will be converted into approximately 15% of the post- restructured equity with participation rights in both the new secured notes and equity, and holders of Seadrill common stock will receive approximately 2% of the post-restructured equity.
- Seadrill has today filed prearranged chapter 11 cases in the Southern District of Texas together with the agreed restructuring plan. Company expects it will pay all suppliers and vendors in full under normal terms for goods and services provided during the chapter 11 cases. At the point of filing, Seadrill has over $1 billion in cash and does not require debtor-in-possession financing. The restructuring agreement contemplates a balance sheet restructuring that is not intended to affect the operations.
- North Atlantic Drilling (NADL), a majority owned subsidiary of Seadrill Limited, entered into a restructuring agreement with more than 97 percent of the Group's secured bank lenders, approximately 40 percent of the Group's bondholders and a consortium of investors, led by Seadrill's largest shareholder, Hemen Holding Ltd.
ML
* COVESTRO - Bayer sells $1.4b for EU63.25/shr; Barclays & Citi on the deal....
* ERAMET - Holders sell $220m at EU57/shr; BNP/IMI and UCG on the placing......
SEADRILL - Files for bankruptcy to shrink offshore Driller's debt..............
RICHEMONT - 5m sales +12% cFX v +10% cons. We DOUBLE upgrade to BUY (90)..+1-2%
ASR - Small +ve. Has acquired dutch ops from Generali for EUR143m (34.2)....+1%
ASML - New iPhones all start at 64GB storage space, no 32GB model now(135)+0.5%
BAYER - Reduces Covestro stake to 31.5% from 40.9%, raise EUR1.2bn (112)..+0.5%
SANOFI - Names Guillaume Leory as chairman for France from Oct 1st (82.04)..u/c
SOCO - Broadly inline nos with production averaging 8.6kboe/d in H1 (118.5).u/c
MINERS - Brent unch, Copper -0.3% with miners in OZ: BHP +0.8%, RIO +1.3..-0.5%
INDITEX - We DOWNGRADE to Neutral on slowing LFL and FX headwinds (31.73)...-1%
DIALOG - Travel & arrive, later delivery on the iPhone will weigh (39.9)....-2%
MainFirst Pre Mkt Indications
*RICHEMONT-5m Sales 12%(10),Euro 3%(11),APAC 23%(11),NA 9%(9).......-2% *VOESTALPINE-Says it was raided yesterday by German Antitrust.......-1% *ADP-Paris Airports Traffic +3.8%,9.84mln passengers................+0.25% *ROCHE-Study shows Esbriet/Nintedanib combo well tolerated..........+0.25% *GENERALI-Agrees sale of Dutch bizz to ASR Nederland for €143m......U/C *CLARIANT-Enters partnership with Tiangang in China.................+0.25% *COVESTRO-ABB of €1.2b,stake from Bayer,via Citi/Barcap,€63.25......-2% *ERAMET-ABB of 2.97m shs,stakes from Intesa & Unicredit,at €57......-8% *AMS/DIALOG-Iphone launch the X version will 3/11(delayed)..........-2% *SILTRONIC-Lock up expires today,last placing €55.85(€85.56)........-1% *ORANGE-Govt must stop rmrs on sale of stake say Unions(13.39%).....U/C
Shore
BALFOUR BEATTY - Sale of Blackpool Airport for 4.25m.........................+1% GALLIFORD TRY - Fy ptp 58.7m.Divi 64p.Outlook remains positive...............+1% DUNELM - Fy sales 955.6m(Est955m).sales in first 2 months started positively.+3% JUST GROUP - H1 op pft 100.6m.Divi 1.17p.Outlook remains favourable..........+1% HALFORDS - Appointment of Graham Stapleton as CEO...........................UNCH
EPWIN - H1 revs +4.6%,PBT -27.9%,rising input costs a challenge to pass on...-5% ADV MEDICAL - grp revs +17%,LiquiBand sales strong,PBT +27%,sees FY in line.UNCH BAGIR - sales levels have been slightly slower than forecast...............-tive WILMINGTON - revs +14%,PBT +5%,slow start to first 2 months of of new year...-2% GLENCORE/RIO - speculation in the FT the merger plan might be revived........+1% SOCO - H1 losses narrow to $6.7m,maintains FY production g'dance.............+1%
RBC:
*AIR FRANCE: +1% group analyst dinner feedback, positive on Q3 & Q4 pricing & volume.*BALFOUR: 0% sale of Blackpool Aiport for £4.25M.
*BMW: -1% negative presentation @ Frankfurt Motor Show.
*CLARIANT: 0% enters partnership with Tiangang in China.
*COVESTRO: -3% Bayer sells Covestro stake @ €63.25 per share.
*DUNELM: -2% FY numbers in line, UK consumer outlook tough.
*EASYJET: +1% launches "Worldwide by EasyJet", global airline service.
*EUROTUNNEL: 0% August traffic solid, passenger shuttles +3% & truck shuttles +1%.
*JUST GROUP: +3% H1 numbers strong, FY outlook remains favourable.
*RICHEMONT: 0% 5-month sales +12% versus +10% consensus, strong into numbers.
*SOCO: 0% H1'17 numbers in line, capex reduced as expected, cash beat.
*VOESTAPLINE: -1% raided by German Antitrust Regulator.
Investec:
UK
* ADV.MED.SOLS-H1.Mixed but in line, sml U/G to FY17 EPS. Travel & arrive...-1%* BALFOUR BEATTY-Sale of Blackpool Airport for £4.25m cash.................unch
* DUNELM-H1.PTP sml miss, EPS ahead. Encouraging start to yr................+1%
* GALIFORD TRY-FY.#'s in line. Upbeat outlook across all business's.......+1-2%
* GLENCORE/RIO-Merger plan may be revived (FT).............................unch
* HALFORDS-Graham Stapleton appointed new Cheif Exec.(from Jan '18).......+1-2%
* JUST GRP-H1.#'s in line, outlook remains 'favourable' for key business...unch
* QUANTUM PHARM-Rec offer from CLIN LN,82p(cash&shares)Closed 66.375p......+15%
* SOCO INTL-H1.Trading in line reits FY guidance...........................unch
* U&I GRP-Realises £4.9m profit through 2 project disposals................unch
EURO
* APPLE SUPPLIERS-phone launch seen +ive for STM FP,AIXA GY,AMS SW etc......+1%
* CLARIANT-enters production partnership with Tiangang in China.............+1%* COVESTRO-sale last night by BAYER of further stake, priced €63.25.........-3%
* ERAMET-Intesa and Unicredit sell stakes via abb, 11.2%, priced €57........-5%
* EUROTUNNEL-Aug passengers +3% YoY, trucks +1%.............................+1%
* GENERALI-sells Dutch ops for €143m........................................U/C
* ORANGE-Govt must stop rmrs of stake sale says Union.......................+1%
* RICHEMONT-5m sales +12% vs est +10%. APAC offset weak EU..................+2%
CS:
AMS -3-5% Delay in iPhone X shipping, from 3rd NovemberASR Ned +1% ASR Buys Generali’s Dutch Operations for EU143m
Dialog Semi -2% Delay in iPhone X shipping, from 3rd November
Dunelm +2-3% Sales £955.6m vs cons £955m, dividend slightly better
Galliford +1% FY revs inline, strong performance across all 3 businesses
Glencore UNCH Rio Merger plan spec commentary in the FT
Just Group +1-2% New business ahead, op profit beat, guiding margins higher
Miners UNCH Copper -0.20%, Brent -0.35%, Iron Ore -2.30%, China -0.20%
Oils -0.5% US API showed a build of 6.2m barrels vs 2.79m last week
Richemont -1% 5m trading update - Sales +12% vs exp +10%
Rio UNCH Glencore Merger plan spec commentary in the FT
Swatch -2% Negative read from the new Apple watch
Commerz:
1COV -2.6% Bayer places c. 9% @ €63.25, reducing direct stake to 31.9%AIXA -3.0% Morgan Stanley cuts to Underweight (Overweight)
COM -0.5% Activist Investor Petrus attacks Commerzbank on its COM holding
DLG -2.8% we up adj EBIT by c 8% for 2018 + 19, on richer IPhone content
KCO +2.0% HSBC starts with Buy, PT €12
KGX +0.6% Goldman Sachs rates new Neutral, PT €79
MRK +0.2% Berenberg raised to Buy (Hold), PT €116
UN01 -0.2% Nord/LB cuts to Sell (Buy), PT €19
Citi:
EURO
*Clas Ohlson -Starts strategic review to expand business. u/c
*Generali -Sells Dutch ops to ASR for 143m. u/c
*ASR -Buys Generali's Dutch ops for 143m. +1%
*ADP -Paris Airports august traffic rises 3.8. u/c
*Eramet -Intesa, Unicredit to sell 11.176% in Eramet at €57-bookbuild.-7%
*Richemont -5mnth sales +12% vs est +10%. APAC sales +23% vs est +11%. -1%
*STM -ADR's -1.5% after Apples new product launch -2%
Numis:
* ALLIANCE PHARMA u/c interims all in line with recent TU* BALFOUR BEATTY Mkt: Announced sale of Blackpool Airport for £4.25m cash, in line with Group strategy.
* CLINIGEN bid terms announced for QUANTUM PHARMA 37p + 0.0405 = 82p vs CLIN closed @ 1111p yday vs QP close 67p
* DUNELM: -1%, trading to remain challenging however a decent start to new financial year
* GALLIFORD TRY Mkt: FY figs PBT £58.7m (NSe £56.5m), cautious on outlook but cite strong performance across all 3 businesses.
* HAMMERSON: Mkt, early redemption of £250m of bonds
* JUST GROUP +2% New business margins have continued to improve to 8.9% (5.0% H1 16) , Adjusted operating profit rose by 39% to £67.2m from £48.4m in H1 2016
* SOCO INTERNATIONAL: -2%, H1 production and revenues light. Roger Cagle to retire.
* SQS SOFTWARE MKT Interims in line; shares have performed well since the July update, we move to ADD from BUY
* TEN ENTERTAINMENT: +2/3%, Current trading strong as YTD lfl sale +3.6% and interim div 3.0p over double expected DPS.
* WILMINGTON: -2%, slight miss to numbers and increased costs added to 2018, also FD exits next year